
Industrials · Electrical Components & Equipment
$230.11
-2.29%
Vol: 1.6M
Friday, May 1, 2026
AMETEK announced record first quarter 2026 results with sales of $1.93 billion (up 11% year-over-year) and adjusted EPS of $1.97 (up 13% YoY), beating analyst estimates. The company raised its full-year 2026 adjusted EPS guidance to $7.94-$8.14 and expects overall sales up high single digits. The board approved a 10% increase in the quarterly dividend to $0.34 per share. Orders rose 23%, backlog reached record levels, and adjusted operating margin expanded to 26.8%.
AMETEK reported record Q1 2026 with sales of $1.93 billion (up 11% YoY), adjusted EPS $1.97 (up 13% YoY), and record backlog with 23% order growth. Management raised 2026 adjusted EPS guidance to $7.94-$8.14 and expects full-year sales up high single digits. Company announced definitive agreement to acquire First Aviation Services, a leading defense and aviation MRO provider with $80 million annual sales and six U.S. centers of excellence. Board approved 10% dividend increase to $0.34 per share from $0.31. Recent acquisition of LKC Technologies for ophthalmic diagnostics.
AMETEK announced acquisition of LKC Technologies, provider of innovative ophthalmic diagnostic solutions. Board approved 10% increase in quarterly dividend to $0.34 per share from $0.31. Q4 2025 sales reached record $2.0 billion, up 13% year-over-year. Q1 2026 earnings release April 30 with analyst expectations of $1.90 EPS, up 8.6% from year-ago quarter. Backlog at $3.58 billion with $100 million investment in growth initiatives.
AMETEK announced a 10% dividend increase to $0.34 per share, signaling confidence in future cash flows. The company reported a $3.58 billion backlog and plans $100 million in growth investments. May 5 earnings guidance expects 3.7% EPS growth and 10.5% revenue increase. Recent institutional buying (Massachusetts Financial Services added 94,544 shares) contrasts with 24-hour decline of 3.89%.
AMETEK reported record backlog of $3.58 billion and outlined plans to deploy $100 million into targeted growth initiatives while reaffirming focus on mergers and acquisitions, driving stock up 7.6%. Innovation now drives approximately one-third of recent revenue growth. Management issued guidance for mid-to-high single-digit sales growth in 2026 with expectations for 3.7% EPS growth and 10.5% revenue increase.
AMETEK announced record fourth-quarter 2025 results with sales of $2.0 billion, up 13% year-over-year, and adjusted EPS of $2.01. Full-year 2025 sales reached $7.4 billion (+7% YoY) with adjusted EPS of $7.43 (+9% YoY). The company reported a record backlog of $3.58 billion and noted that recent innovations now drive approximately one-third of revenue growth. For 2026, AMETEK projects mid-to-high single-digit sales growth with adjusted EPS of $7.87-$8.07. The company also increased its quarterly dividend by 10% to $0.34 per share.
AMETEK reported record Q4 2025 backlog of $3.58 billion and mid-to-high single-digit sales growth guidance for 2026. The company announced a 10% dividend increase to $0.34 per share and completed acquisition of LKC Technologies for ophthalmic diagnostics. BMO initiated Outperform coverage citing diversified business mix. Q4 2025 adjusted EPS of $2.01 (+9% YoY). 2026 guidance: adjusted EPS $7.87-$8.07.
AMETEK (AME) closed April 6 at $218.42 with a 44% 12-month gain. BMO Capital initiated coverage with an Outperform rating following the company's acquisition of LKC Technologies, extending its Electronic Instruments Group into ophthalmic diagnostics. CCLA Investment Management increased its stake by 12,907 shares on April 9. Industrial stocks rallied 3.8% on April 9, benefiting AME.
AMETEK Inc. shares jumped 5.33% on April 8, 2026, as board approved 10% dividend increase to $0.34 per share. Stock at $229.35, reflecting upward momentum from mixed analyst sentiment. EPS expected to grow 3.7% with 10.5% revenue growth expected. Company benefits from partnerships in cryocooler technology and continues global expansion across 30+ countries. Analyst consensus Outperform (21 firms, avg rating 2.2) with 12-month target $248.80, implying 8.48% upside. Recent activity includes Deutsche Bank naming as short-term buy idea (March 30) while Baird lowered target to $235 from $245. Earnings April 5, 2026.
AMETEK completed its acquisition of FARO Technologies (3D measurement/imaging) and joined the Ultra Precision Technologies Division. Recent analyst actions include BMO Capital initiating an Outperform rating and Deutsche Bank naming it a short-term buy idea. The company benefits from accelerating adoption of digital reality, automation, and advanced metrology in aerospace, defense, and architecture markets. Stock trades at $218.42. Baird lowered price target to $235 from $245 while Morgan Stanley maintains Hold.
AMETEK Q4 2025 EPS $2.01, record sales $2B (+13%). Operating income $523M (+12%) at 26.2% margins. Record backlog $3.58B. 10% dividend hike to $0.34. 2026 EPS guide $7.87-8.07. BMO initiated Outperform after LKC Tech acquisition. Stock $212.27.
AMETEK Inc. (AME) completed acquisition of ophthalmic diagnostics specialist LKC Technologies for integration into Electronic Instruments Group. BMO Capital analyst Daniel DiCicco initiated coverage with Outperform rating in early April 2026. AME trades at $218.29 with 30-day return of 7.21%, 1-year return of 36.05%, and 3-year return of 64.57%. Average analyst target of $249.89 vs. current price suggests upside potential. Ascent Group LLC reduced stake by 12.6% in Q4 (now 33,418 shares, $6.86M), while HBE Wealth Management purchased 6,025 shares ($1.24M) in Q4 2025. The company's diversified business mix and shorter-cycle operations attracted fresh institutional attention with BMO's Outperform initiation.
AMETEK reported record Q4 2025 sales of $2.0 billion (13% YoY increase) and EPS of $2.01, beating estimates of $1.94. The company raised full-year 2026 guidance to $7.87-$8.07 EPS. Management projects mid- to high-single-digit sales growth. The company approved a 10% increase in quarterly dividends to $0.34 per share and completed the acquisition of LKC Technologies.
AMETEK announced record fourth-quarter 2025 sales of $2.0 billion, representing 13% growth over Q4 2024, with earnings per share of $2.01 beating estimates of $1.94. The board approved a 10% dividend increase to $0.34 per share. The company also acquired LKC Technologies for ophthalmic diagnostic solutions. Analysts DA Davidson and Truist both raised price targets to $265 with Buy ratings, citing solid performance and record backlog levels. The stock is positioned for continued growth in 2026.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| ETNEATON | $425.67 | -1.70% | +19.0% | 28.0x | 1.16 | $168.0B |
| EMREMERSON | $137.47 | -2.11% | +5.9% | 19.6x | 1.28 | $78.9B |
| AMEAMETEK | $230.11 | -2.29% | +7.8% | 27.0x | 1.04 | $53.9B |
| ROKROCKWELL | $408.00 | -0.22% | +11.4% | 29.8x | 1.54 | $46.0B |
| GNRCGENERAC | $259.27 | +0.02% | +32.6% | 24.8x | 1.79 | $15.2B |
| CATCATERPILLAR | $890.93 | +0.09% | +23.4% | 31.8x | 1.52 | $414.2B |
Price above both MAs — bullish structure.